Skip to main content

Complement System and the Eye

  • Conference paper
Current Topics in Complement

Part of the book series: Advances in Experimental Medicine and Biology ((volume 586))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

6. References

  1. J.P. Atkinson, M.M. Frank, Complement. In Clinical immunology, edited by C.W. Parker (WB Saunders, Philadelphia 1980), pp. 219–271.

    Google Scholar 

  2. G.D. Ross, Immunobiology of the complement system (Academic Press Inc., Florida, 1986).

    Google Scholar 

  3. H.J. Muller-Eberhard, Molecular organization and function of the complement system, Annu Rev Biochem 57, 321–347 (1988).

    Article  PubMed  CAS  Google Scholar 

  4. M.M. Frank and L.F. Fries, The role of complement in inflammation and phagocytosis, Immunol Today 12, 322–326 (1991).

    Article  PubMed  CAS  Google Scholar 

  5. S. Thomlinson, Complement defense mechanisms, Curr Opin Immunol 5, 83–89 (1993).

    Article  Google Scholar 

  6. K.B.M. Reid, Activation and control of the complement system, Essays Biochem 22, 27–68 (1986).

    PubMed  CAS  Google Scholar 

  7. B.P. Morgan and C.L. Harris, The complement system: a brief overview, in: Complement regulatory proteins, edited by B.P. Morgan and C.L. Harris (Academic Press, San Diego 1999), pp 1–31.

    Google Scholar 

  8. S. Thiel, T. Vorup-Jensen, C.M. Stover, W. Schwaeble, S.B. Laursen, K. Poulsen, A.C. Willis, P. Eggleton, S. Hansen, U. Holmskov, K.B. Reid, and J.C. Jensenius, A second serine protease associated with mannan-binding lectin that activates complement, Nature, 386, 506 (1997).

    Article  PubMed  CAS  Google Scholar 

  9. M.K. Liszewski, T.C. Farries, D.M. Lublin, I.A. Rooney, and J.P. Atkinson, Control of the complement system, Adv Immunol 61, 201–283 (1996).

    Article  PubMed  CAS  Google Scholar 

  10. J.P. Atkinson, and T. Farries, Separation of self from non-self in the complement system, Immunol Today 8, 212–215 (1987).

    Article  CAS  Google Scholar 

  11. D.M. Lublin, and J.P. Atkinson, Decay-accelerating factor and membrane cofactor protein, Curr Top Microbiol Immunol 153, 123–145 (1987).

    Google Scholar 

  12. A. Nicholson-Weller, Decay accelerating factor (CD55) Curr Topics Microbiol Immunol 178, 7–30 (1992).

    CAS  Google Scholar 

  13. M.K. Liszewski, T.W. Post, and J.P. Atkinson, Membrane cofactor protein (MCP or CD46): Newest member of the regulators of complement activation gene cluster, Ann Rev Immunol 9, 431–455 (1991).

    Article  CAS  Google Scholar 

  14. M.K. Liszewski, and J.P. Atkinson, Membrane cofactor protein, Curr Topics Microbiol Immunol 178, 45–60 (1992).

    CAS  Google Scholar 

  15. M.H. Holguin and C.J. Parker, Membrane inhibitor of reactive lysis. Curr Topics Microbiol Immunol 178, 61–85 (1992).

    CAS  Google Scholar 

  16. M.J. Watts, J.R. Dankert, and B.P. Morgan, Isolation and characterization of a membrane-attack-complex inhibiting protein present in human serum and other biological fluids, Biochem J 265, 471–477 (1990).

    PubMed  CAS  Google Scholar 

  17. Y-U. Kim, T. Kinoshita, H. Molina, D. Hourcade, T. Seya, L.M. Wagner, and V.M. Holers, Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein, J Exp Med 181, 151–159 (1995).

    Article  PubMed  CAS  Google Scholar 

  18. H. Takizawa, N. Okada, and H. Okada, Complement inhibitor of rat cell membrane resembling mouse Crry/p65, J Immunol 152, 3032–3038 (1994).

    PubMed  CAS  Google Scholar 

  19. H. Molina, W. Wong, T. Kinoshita, C. Brenner, S. Foley, and V.M. Holers, Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1, J Exp Med 175, 121–129 (1992).

    Article  PubMed  CAS  Google Scholar 

  20. B. Li, C. Sallee, M. Dehoff, S. Foley, H. Molina, and V.M. Holers, Mouse Crry/p65: characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF, J Immunol 151(8), 4295–4305 (1993).

    PubMed  CAS  Google Scholar 

  21. M.B. Powell, K.J. Marchbank, N.K. Rushmere, C.W. van den Berg, and B.P. Morgan, Molecular cloning, chromosomal localization, expression, and functional characterization of the mouse analogue of human CD59, J Immunol 158(4), 1692–1702 (1997).

    PubMed  CAS  Google Scholar 

  22. Y.M. Qian, X. Qin, T. Miwa, X. Sun, J.A. Halperin, and W.C. Song, Identification and functional characterization of a new gene encoding the mouse terminal complement inhibitor CD59, J Immunol 165, 2528–2534 (2000).

    PubMed  CAS  Google Scholar 

  23. J.H. Sohn, H.J. Kaplan, H.J. Suk, P.S. Bora, and N.S. Bora, Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins, Invest Ophthalmol Vis Sci 41(11), 3492–502 (2000).

    PubMed  CAS  Google Scholar 

  24. J.H. Sohn, H.J. Kaplan, H.J. Suk, P.S. Bora, and N.S. Bora, Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59, Invest Ophthalmol Vis Sci 41(13), 4195–4202 (2000).

    PubMed  CAS  Google Scholar 

  25. N.S. Bora, C.L. Gobleman, J.P. Atkinson, J.S. Pepose, and H.J. Kaplan, Differential expression of the complement regulatory proteins in the human eye, Invest Ophthalmol Vis Sci 34(13), 3579–3584 (1993).

    PubMed  CAS  Google Scholar 

  26. D.S. Bardenstein, Y. Dietz, J.H. Lass, and M.E. Medof, Localization of the complement membrane attack complex inhibitor (CD59) in human conjunctiva and lacrimal gland, Curr Eye Res 13(12), 851–855 (1994).

    PubMed  CAS  Google Scholar 

  27. B.J. Mondino, S.I. Brown, B.S. Rabin, and J. Bruno, Alternate pathway activation of complement in a Proteus mirabilis ulceration of the cornea, Arch Ophthalmol 96(9), 1659–1661 (1978).

    PubMed  CAS  Google Scholar 

  28. R.P. Cleveland, L.D. Hazlett, M.A. Leon, R.S. Berk, Role of complement in murine corneal infection caused by Pseudomonas aeruginosa, Invest Ophthalmol Vis Sci 24(2), 237–242 (1983).

    PubMed  CAS  Google Scholar 

  29. B.J. Mondino, M.M. Glovsky, and L. Chekiere. Activated complement in inflamed aqueous humor, Invest Ophthalmol Vis Sci 25, 871–873 (1984).

    PubMed  CAS  Google Scholar 

  30. B.J. Mondino and H. Sumner, Anaphylatoxin levels in human aqueous humor, Invest Ophthalmol Vis Sci 27, 1288–1292 (1986).

    PubMed  CAS  Google Scholar 

  31. P. Jha, J.H. Sohn, Q. Xu, H. Nishimori, Y. Wang, S. Nishihori, B. Manickam, H.J. Kaplan, P.S. Bora, and N.S. Bora, The complement system plays a critical role in the development of experimental autoimmune anterior uveitis, Invest Ophthalmol Vis Sci 47 (2006).

    Google Scholar 

  32. R.M. Broekhuyse, E.D. Kuhlman, H.J. Winkens, and A.H.M. Van Vugt, Experimental autoimmune anterior uveitis (EAAU), a new form of experimental uveitis, I: induction by a detergent-insoluble, intrinsic protein fraction of the retina pigment epithelium, Exp Eye Res 52, 465–474 (1991).

    Article  PubMed  CAS  Google Scholar 

  33. N.S. Bora, M.C. Kim, N.H. Kabeer, S.C. Simpson, M.T. Tandhasetti, T.P. Cirrito, A.D. Kaplan, and H.J. Kaplan, Experimental autoimmune anterior uveitis. Induction with melanin-associated antigen from the iris and ciliary body, Invest Ophthalmol Vis Sci 36(6), 1056–1066 (1995).

    PubMed  CAS  Google Scholar 

  34. N.S. Bora, M. D. Woon, M. T. Tandhasetti, T. P. Cirrito, and H. J. Kaplan, Induction of experimental autoimmune anterior uveitis by a self-antigen: melanin complex without adjuvant, Invest Ophthalmol Vis Sci 38(10), 2171–2175 (1997).

    PubMed  CAS  Google Scholar 

  35. M.C. Kim, N.H. Kabeer, M.T. Tandhasetti, H.J. Kaplan, and N.S. Bora, Immunohistochemical studies in melanin associated antigen (MAA) induced experimental autoimmune anterior uveitis (EAAU), Curr Eye Res 14(8), 703–710 (1995).

    PubMed  CAS  Google Scholar 

  36. M.D. Woon, H.J. Kaplan, and N.S. Bora, Kinetics of cytokine production in experimental autoimmune anterior uveitis (EAAU), Curr Eye Res 17(10), 955–961 (1998).

    Article  PubMed  CAS  Google Scholar 

  37. N.S. Bora, J.H. Sohn, S.G. Kang, J.M. Cruz, H. Nishihori, H.J. Suk, Y. Wang, H.J. Kaplan, and P.S. Bora, Type I collagen is the autoantigen in experimental autoimmune anterior uveitis, J Immunol 172(11), 7086–7094 (2004).

    PubMed  CAS  Google Scholar 

  38. A.E. Davis 3d, R.A. Harrison, and P.J. Lachmann, Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g, J Immunol 132, 1960–1966 (1984).

    PubMed  CAS  Google Scholar 

  39. F.L. Ferris, S.L. Fine, L. Hyman, Age-related macular degeneration and blindness due to neovascular maculopathy, Arch Ophthalmol 102, 1640–1642 (1984).

    PubMed  Google Scholar 

  40. S.L. Fine, J.W. Berger, M.G. Maguire, A.C. Ho. Age-related macular degeneration. N Engl J Med 342, 483–492 (2000).

    Article  PubMed  CAS  Google Scholar 

  41. L.V. Johnson, M.K. Staples, M.A. de los Rios, M.J. Nealon, S. Ozaki, P.J. Kappel, M.B. Stenkilsson, and D.A. Anderson, Inflammation and the immune response in age-related macular degeneration, Exp Eye Res 67, p. S102 (1998).

    Google Scholar 

  42. L.V. Johnson, P.A. Erickson and D.A. Anderson, Age-related maculopathy: RPE, immune response molecules and drusen biogenesis, Invest Ophthalmol Vis Sci 40, S992 (1999).

    Google Scholar 

  43. R.F. Mullins, S.R. Russell, D.H. Anderson, and G.S. Hageman, Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease, FASEB J 14(7), 835–846 (2000).

    PubMed  CAS  Google Scholar 

  44. L.V. Johnson, S. Ozaki, M.K. Staples, P.A. Erickson, and D.A. Anderson, A potential role for immune complex pathogenesis in drusen formation, Exp Eye Res 70, 441–449 (2000).

    Article  PubMed  CAS  Google Scholar 

  45. L.V. Johnson, W.P. Leitner, M.K. Staples, and D.H. Anderson, Complement activation and inflammatory processes in drusen formation and age related macular degeneration, Exp Eye Res 73, 887–896 (2001).

    Article  PubMed  CAS  Google Scholar 

  46. G.S. Hageman, P.J. Luthert, N.H. Victor Chong, L.V. Johnson, D.H. Anderson, and R.F. Mullins, An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and agerelated macular degeneration, Prog Retin Eye Res 20(6), 705–732 (2001).

    Article  PubMed  CAS  Google Scholar 

  47. G.S. Hageman, D.H. Anderson, L.V. Johnson, L.S. Hancox, A.J. Taiber, L.I. Hardisty, J.L. Hageman, H.A. Stockman, J.D. Borchardt, K.M. Gehrs, R.J. Smith, G. Silvestri, S.R. Russell, C.C. Klaver, I. Barbazetto, S. Chang, L.A. Yannuzzi, G.R. Barile, J.C. Merriam, R.T. Smith, A.K. Olsh, J. Bergeron, J. Zernant, J.E. Merriam, B. Gold, M. Dean, and R. Allikmets, A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration, Proc Natl Acad Sci USA 102(20), 7227–7232 (2005).

    Article  PubMed  CAS  Google Scholar 

  48. H. Miller, B. Miller, T. Ishibashi, and S.J. Ryan, Pathogenesis of laser-induced choroidal subretinal neovascularization, Invest Ophthalmol Vis Sci 31, 899–908 (1990).

    PubMed  CAS  Google Scholar 

  49. H. Kimura, T. Sakamoto, D.R. Hinton, C. Spee, Y. Ogura, and S.J. Ryan, A new model of subretinal neovascularization in the rabbit, Invest Ophthalmol Vis Sci 36, 2110–2119 (1995).

    PubMed  CAS  Google Scholar 

  50. P.S. Bora, J.H. Sohn, J.M. Cruz, P. Jha, H. Nishihori, Y. Wang, S. Kaliappan, H.J. Kaplan, and N.S. Bora, Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization, J Immunol 174(1) 491–497 (2005).

    PubMed  CAS  Google Scholar 

  51. J.W. Streilein, B.R. Ksander, and A.W. Taylor, Immune deviation in relation to ocular immune privilege, J Immunol 158(8), 3557–3560 (1997).

    PubMed  CAS  Google Scholar 

  52. J.W. Streilein, Immunologic privilege of the eye, Springer Semin Immunopathol 21(2), 95–111 (1999).

    Article  PubMed  CAS  Google Scholar 

  53. J.H. Sohn, P.S. Bora, H.J. Suk, H. Molina, H.J. Kaplan, and N.S. Bora, Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells, Nat Med 9(2), 206–212 (2003).

    Article  PubMed  CAS  Google Scholar 

  54. T.J. D’Orazio, and J.Y. Niederkorn, A novel role for TGF-beta and IL-10 in the induction of immune privilege, J Immunol 160(5), 2089–2098 (1998).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, LLC

About this paper

Cite this paper

Jha, P., Bora, P.S., Sohn, JH., Kaplan, H.J., Bora, N.S. (2006). Complement System and the Eye. In: Lambris, J.D. (eds) Current Topics in Complement. Advances in Experimental Medicine and Biology, vol 586. Springer, Boston, MA. https://doi.org/10.1007/0-387-34134-X_4

Download citation

Publish with us

Policies and ethics